Literature DB >> 10802653

Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.

S R Yant1, L Meuse, W Chiu, Z Ivics, Z Izsvak, M A Kay.   

Abstract

The development of non-viral gene-transfer technologies that can support stable chromosomal integration and persistent gene expression in vivo is desirable. Here we describe the successful use of transposon technology for the nonhomologous insertion of foreign genes into the genomes of adult mammals using naked DNA. We show that the Sleeping Beauty transposase can efficiently insert transposon DNA into the mouse genome in approximately 5-6% of transfected mouse liver cells. Chromosomal transposition resulted in long-term expression (>5 months) of human blood coagulation factor IX at levels that were therapeutic in a mouse model of haemophilia B. Our results establish DNA-mediated transposition as a new genetic tool for mammals, and provide new strategies to improve existing non-viral and viral vectors for human gene therapy applications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10802653     DOI: 10.1038/75568

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  166 in total

1.  Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.

Authors:  H Nakai; T A Storm; M A Kay
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

2.  The DNA-bending protein HMGB1 is a cellular cofactor of Sleeping Beauty transposition.

Authors:  Hatem Zayed; Zsuzsanna Izsvák; Dheeraj Khare; Udo Heinemann; Zoltán Ivics
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

3.  Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase.

Authors:  B Thyagarajan; E C Olivares; R P Hollis; D S Ginsburg; M P Calos
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

4.  Towards integrating vectors for gene therapy: expression of functional bacteriophage MuA and MuB proteins in mammalian cells.

Authors:  F H Schagen; H J Rademaker; S J Cramer; H van Ormondt; A J van der Eb; P van de Putte; R C Hoeben
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

5.  Hydroporation as the mechanism of hydrodynamic delivery.

Authors:  G Zhang; X Gao; Y K Song; R Vollmer; D B Stolz; J Z Gasiorowski; D A Dean; D Liu
Journal:  Gene Ther       Date:  2004-04       Impact factor: 5.250

6.  Enhancement of Sleeping Beauty transposition by CpG methylation: possible role of heterochromatin formation.

Authors:  Kosuke Yusa; Junji Takeda; Kyoji Horie
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

7.  Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells.

Authors:  Stephen R Yant; Julie Park; Yong Huang; Jacob Giehm Mikkelsen; Mark A Kay
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

8.  Mobilization of DNA transposable elements from lentiviral vectors.

Authors:  Rasmus O Bak; Jacob Giehm Mikkelsen
Journal:  Mob Genet Elements       Date:  2011-07-01

9.  Sleeping Beauty jumps to new heights.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2010-07       Impact factor: 4.599

10.  Herpes simplex virus/Sleeping Beauty vector-based embryonic gene transfer using the HSB5 mutant: loss of apparent transposition hyperactivity in vivo.

Authors:  Suresh de Silva; Michael A Mastrangelo; Louis T Lotta; Clark A Burris; Zsuzsanna Izsvák; Zoltán Ivics; William J Bowers
Journal:  Hum Gene Ther       Date:  2010-10-22       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.